Delivery Order SPE2DR25D1017-SPE2DR26F9ADD
- Not listed
- The Defense Logistics Agency awarded a $21,479.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. This is a non-set-aside competitive award with an ultimate completion date of November 5, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be performed from the contractor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency (DLA) awarded a $5,709.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-set-aside competitive award reflects continued reliance on AmerisourceBergen's pharmaceutical distribution capabilities to support federal medical supply needs. The delivery order is set to conclude by November 6, 2025, with performance executed from the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a $12,072.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-competitive delivery order, which is set to be completed by November 18, 2025, represents a routine pharmaceutical procurement for the federal medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense...
- The Defense Logistics Agency awarded a $27,169.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on November 24, 2025, with completion targeted for November 25, 2025. This firm fixed price, non-set-aside delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $62,628.81 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, awarded on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a non-competitive, non-set-aside procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's extensive...
- The Defense Logistics Agency awarded a $3,267.57 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 30, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,061.39 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, awarded on October 27, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors, with a contract ceiling value of $2,327.44 and an ultimate completion date of November 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $6,948.71 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 5, 2025. This non-competitive, firm fixed-price delivery order was issued on November 4, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA's Medical...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9ADDDelivery Order
The Defense Logistics Agency awarded a $5,434.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside competitive award will be fulfilled from the vendor's place of business in Conshohocken, Pennsylvania, with an ultimate completion date of November 25, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, leverages this IDC vehicle to supply a broad spectrum of medications and medical supplies supporting military healthcare operations globally. The Repatha product being delivered under this order is a cholesterol-lowering injectable medication used in cardiovascular treatment regimens. As a prime vendor under the DLA Medical Supply Chain framework, AmerisourceBergen Drug Corp maintains the capability to fulfill recurring federal procurement requirements for specialized pharmaceuticals and auto-injector delivery systems across multiple therapeutic domains, supporting the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 11/23/25 |